NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Measurements of human herpesvirus 8 viral load in blood before and after leukoreduction filtration.

Author(s): Dollard SC, Roback JD, Gunthel C, Amin MM, Barclay S, Patrick E, Kuehnert MJ

Publication: Transfusion, 2013, Vol. 53, Page 2164-7

PubMed ID: 23362994 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of leukoreduction filtration on levels of human herpes virus 8 (HHV-8) in blood and to compare HHV-8 load in blood and plasma from human immunodeficiency virus (HIV) positive men with and without Karposi's sarcoma (KS).

Conclusion of Paper

Before leukofiltration, 12 of 21 blood specimens from patients with KS had detectable HHV-8, but after leukofiltration, only 5 of 21 specimens from patients with KS had detectable HHV-8. Further, the HHV-8 levels were more than 10 fold lower after leukofiltration of blood than before leukofiltration. Plasma levels of HHV-8 were generally comparable to levels in leukofiltered blood and were 1-20% of those in unfiltered blood. In the 12 patients with detectable HHV-8 in blood specimens, there was an inverse relationship between HHV-8 viral load and CD4 count. HHV-8 was not detectable in the blood of patients without KS.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of leukoreduction filtration on HHV-8 viral load in blood and to compare HHV-8 load in blood and plasma from HIV positive men with and without KS. Blood was collected in acid-citrate-dextrose (ACD), frozen at -80 degrees C, and transported the same day or the next day, but the transport method and distance were not specified. Once in the laboratory, an aliquot of blood was removed to obtain plasma, another was removed for assay, and the remaining blood was leukoreduced. The method used to determine CD4 count was not specified.

    Summary of Findings:

    Before leukofiltration, 12 of 21 blood specimens from patients with KS had detectable HHV-8, but after leukofiltration, only 5 of 21 specimens from patients with KS had detectable HHV-8. Further, the HHV-8 levels were more than 10 fold lower after leukofiltration of blood than before leukofiltration. Plasma levels of HHV-8 were generally comparable to levels in leukofiltered blood and were 1-20% of those in unfiltered blood. In the 12 patients with detectable HHV-8 in blood, there was an inverse relationship between HHV-8 viral load and CD4 count (Spearman's rank coefficient, -0.615; p = 0.03). HHV-8 was not detectable in the blood of patients without KS.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • AIDS/HIV-related
    Platform:
    AnalyteTechnology Platform
    DNA Real-time qPCR
    Cell count/volume Flow cytometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Whole blood
    Biospecimen Aliquots and Components Filtration Not filtered
    Leukoreduction filtered
    Preaquisition Diagnosis/ patient condition Karposi's Sarcoma
    No Karposi's Sarcoma

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...